- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Mycosis fungoides-type cutaneous T-cell lymphoma (MF-type CTCL)
- Meeting Date: November 2023
- Public Summary Document (PSD) November 2023 PBAC Meeting - (PDF 802KB)
- Public Summary Document (PSD) November 2023 PBAC Meeting - (Word 289KB)
Chlormethine hydrochloride – November 2023
Chlormethine hydrochloride: Gel 160 micrograms per g, 60 g; Ledaga®
Last updated
1 March 2024